Bertil Johansson
61 – 70 of 207
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Submicroscopic genomic imbalances in burkitt lymphomas/leukemias: Association with age and further evidence that 8q24/MYC translocations are not sufficient for leukemogenesis.
- Contribution to journal › Article
- 2012
-
Mark
Whole-exome sequencing of pediatric acute lymphoblastic leukemia.
- Contribution to journal › Article
-
Mark
Myeloid malignancies with acquired trisomy 21 as the sole cytogenetic change are clinically highly variable and display a heterogeneous pattern of copy number alterations and mutations(a).
- Contribution to journal › Article
-
Mark
Additional aberrations of the ETV6 and RUNX1 genes have no prognostic impact in 229 t(12;21)(p13;q22)-positive B-cell precursor acute lymphoblastic leukaemias treated according to the NOPHO-ALL-2000 protocol
(2012) In Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis 36(7). p.936-938
- Contribution to journal › Letter
-
Mark
Homozygous deletions of CDKN2A are present in all dic(9;20)(p13.2;q11.2)-positive B-cell precursor acute lymphoblastic leukaemias and may be important for leukaemic transformation
- Contribution to journal › Letter
-
Mark
High frequency of BTG1 deletions in acute lymphoblastic leukemia in children with down syndrome.
- Contribution to journal › Article
-
Mark
Disease-associated patterns of disomic chromosomes in hyperhaploid neoplasms.
- Contribution to journal › Article
- 2011
-
Mark
The frequency and prognostic impact of dic(9;20)(p13.2;q11.2) in childhood B-cell precursor acute lymphoblastic leukemia: results from the NOPHO ALL-2000 trial
- Contribution to journal › Article
-
Mark
Amplification of the G allele at SNP rs6983267 in 8q24 amplicons in myeloid malignancies as cause of the lack of MYC overexpression?
- Contribution to journal › Letter
-
Mark
Paediatric B-cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols.
- Contribution to journal › Article
